1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-260
  5. Product Images: Losartan Potassium

Product Images Losartan Potassium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Losartan Potassium NDC 71610-260 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bottle Label 25 mg - 71610 0260 30

Bottle Label 25 mg - 71610 0260 30

Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01

Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01

figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02

figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02

The text appears to be a graph or chart showing the percentage of patients who achieved the primary endpoint in a study involving Atenolol and Losartan Potassium Tablets. It also shows an adjusted risk reduction of 13% with a p-value of 0.021. The study was conducted for 60-65 months.*

figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03

figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03

This appears to be a comparison of the effectiveness of Atenolol and Losartan Potassium Tablets on patients with fatal or non-fatal stroke. The graph provides data for the adjusted risk reduction of stroke, showing a 25% reduction in risk for the Losartan group compared to the Atenolol group with a p-value of 0.001. The study seems to have been conducted over a period of 68 months, with data points provided for each month within that timeframe.*

figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04

figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04

figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05

figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05

This appears to be a table or chart showing the percentage of patients experiencing an event in different populations. The table also includes a possible measure of risk reduction and a reference to Losartan Potassium Tablets and a Placebo. However, without further context or information, it is not possible to determine the precise purpose or meaning of this information.*

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07

Aphena Pharma Solutions - TN - Aphena

Aphena Pharma Solutions - TN - Aphena

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.